Library Newsletter

Issue 10, 2009


Issue 28, 2014        Issue 27, 2014        Issue 26, 2014        Issue 25, 2014        

Issue 24, 2013        Issue 23, 2013        Issue 22, 2013        Issue 21, 2013        

Issue 20, 2012        Issue 19, 2012        Issue 18, 2011        Issue 17, 2011        

Issue 16, 2010        Issue 15, 2010        Issue 14, 2010        Issue 13, 2010        

Issue 12, 2009        Issue 11, 2009        Issue 10, 2009        Issue  9, 2009        

Issue  8, 2008        Issue  7, 2008        Issue  6, 2008        Issue  5, 2008        

Issue  4, 2007        Issue  3, 2007        Issue  2, 2007        Issue  1, 2007        




News 
Publications 
Web Sights 
Multimedia 
Other Issues 


  News  
Drug Policy Analysis: A Journal of Substance Abuse Control Policy
Berkeley Electronic Press
Berkeley Electronic Press announces the launch of Drug Policy Analysis:
A Journal of Substance Abuse Control Policy. Journal of Drug Policy
Analysis focuses on practical, policy-analytic insights on the problems
and policies of drug abuse control. Short peer-reviewed articles and
essays analyze every aspect of the policy problems posed by abusable
psychoactives, licit and illicit, anywhere in the world.
Readers may access any of the journal’s articles at no charge. You may
also sign up to receive ongoing email alerts of new content at
http://www.bepress.com/jdpa.
Using data-driven and conceptual approaches, as well as the methods of
the social and biological sciences, the humanities, medicine, public
health, law, law enforcement, and public management, the journal
emphasizes informed policy analysis: the stakes in a given policy
choice, and the terms of the tradeoffs among the values and interests in
play.
Edited by Mark Kleiman (UCLA) and Beau Kilmer (RAND), Journal of Drug
Policy Analysis drives the public and scholarly conversation about how
to deal with the issues surrounding drug policy, a conversation of vital
interest to drug policy researchers, criminologists, economists,
physicians, and those who make decisions about drug policy.

[·link·]

Contact Us Disclaimer | Acknowledgements